These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 10335271)

  • 1. Antineoplastic agents 393. Synthesis of the trans-isomer of combretastatin A-4 prodrug.
    Pettit GR; Rhodes MR; Herald DL; Chaplin DJ; Stratford MR; Hamel E; Pettit RK; Chapuis JC; Oliva D
    Anticancer Drug Des; 1998 Dec; 13(8):981-93. PubMed ID: 10335271
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Antineoplastic agents 429. Syntheses of the combretastatin A-1 and combretastatin B-1 prodrugs.
    Pettit GR; Lippert JW
    Anticancer Drug Des; 2000 Jun; 15(3):203-16. PubMed ID: 11049088
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Antineoplastic agents 322. synthesis of combretastatin A-4 prodrugs.
    Pettit GR; Temple C; Narayanan VL; Varma R; Simpson MJ; Boyd MR; Rener GA; Bansal N
    Anticancer Drug Des; 1995 Jun; 10(4):299-309. PubMed ID: 7786396
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Antineoplastic agents 389. New syntheses of the combretastatin A-4 prodrug.
    Pettit GR; Rhodes MR
    Anticancer Drug Des; 1998 Apr; 13(3):183-91. PubMed ID: 9595032
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Antineoplastic agents 460. Synthesis of combretastatin A-2 prodrugs.
    Pettit GR; Moser BR; Boyd MR; Schmidt JM; Pettit RK; Chapuis JC
    Anticancer Drug Des; 2001; 16(4-5):185-93. PubMed ID: 12049477
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Antineoplastic agents. 509: synthesis of fluorcombstatin phosphate and related 3-halostilbenes(1).
    Pettit GR; Minardi MD; Rosenberg HJ; Hamel E; Bibby MC; Martin SW; Jung MK; Pettit RK; Cuthbertson TJ; Chapuis JC
    J Nat Prod; 2005 Oct; 68(10):1450-8. PubMed ID: 16252907
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Antineoplastic agents 463. Synthesis of combretastatin A-3 diphosphate prodrugs.
    Pettit GR; Minardi MD; Boyd MR; Pettit RK
    Anticancer Drug Des; 2000 Dec; 15(6):397-403. PubMed ID: 11716432
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Antineoplastic agents 453. Synthesis of pancratistatin prodrugs.
    Pettit GR; Orr B; Ducki S
    Anticancer Drug Des; 2000 Dec; 15(6):389-95. PubMed ID: 11716431
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Antineoplastic agents. 578. Synthesis of stilstatins 1 and 2 and their water-soluble prodrugs.
    Pettit GR; Thornhill A; Melody N; Knight JC
    J Nat Prod; 2009 Mar; 72(3):380-8. PubMed ID: 19228038
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Antineoplastic agents. 379. Synthesis of phenstatin phosphate.
    Pettit GR; Toki B; Herald DL; Verdier-Pinard P; Boyd MR; Hamel E; Pettit RK
    J Med Chem; 1998 May; 41(10):1688-95. PubMed ID: 9572894
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Antineoplastic agents. 445. Synthesis and evaluation of structural modifications of (Z)- and (E)-combretastatin A-41.
    Pettit GR; Rhodes MR; Herald DL; Hamel E; Schmidt JM; Pettit RK
    J Med Chem; 2005 Jun; 48(12):4087-99. PubMed ID: 15943482
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Antineoplastic agents 442. Synthesis and biological activities of dioxostatin.
    Pettit GR; Lippert JW; Boyd MR; Verdier-Pinard P; Hamel E
    Anticancer Drug Des; 2000 Oct; 15(5):361-71. PubMed ID: 11354312
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Synthesis and biological evaluation of vinylogous combretastatin A-4 derivatives.
    Kaffy J; Pontikis R; Florent JC; Monneret C
    Org Biomol Chem; 2005 Jul; 3(14):2657-60. PubMed ID: 15999202
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Antineoplastic agents. 291. Isolation and synthesis of combretastatins A-4, A-5, and A-6(1a).
    Pettit GR; Singh SB; Boyd MR; Hamel E; Pettit RK; Schmidt JM; Hogan F
    J Med Chem; 1995 May; 38(10):1666-72. PubMed ID: 7752190
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Development of synthetic methodology suitable for the radiosynthesis of combretastatin A-1 (CA1) and its corresponding prodrug CA1P.
    Shirali A; Sriram M; Hall JJ; Nguyen BL; Guddneppanavar R; Hadimani MB; Ackley JF; Siles R; Jelinek CJ; Arthasery P; Brown RC; Murrell VL; McMordie A; Sharma S; Chaplin DJ; Pinney KG
    J Nat Prod; 2009 Mar; 72(3):414-21. PubMed ID: 19161336
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Antineoplastic agents. 579. Synthesis and cancer cell growth evaluation of E-stilstatin 3: a resveratrol structural modification.
    Pettit GR; Melody N; Thornhill A; Knight JC; Groy TL; Herald CL
    J Nat Prod; 2009 Sep; 72(9):1637-42. PubMed ID: 19719153
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Antineoplastic agents. 465. Structural modification of resveratrol: sodium resverastatin phosphate.
    Pettit GR; Grealish MP; Jung MK; Hamel E; Pettit RK; Chapuis JC; Schmidt JM
    J Med Chem; 2002 Jun; 45(12):2534-42. PubMed ID: 12036362
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Regio- and stereospecific synthesis of mono-beta-d-glucuronic acid derivatives of combretastatin A-1.
    Tanpure RP; Strecker TE; Chaplin DJ; Siim BG; Trawick ML; Pinney KG
    J Nat Prod; 2010 Jun; 73(6):1093-101. PubMed ID: 20496923
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Solution-phase parallel synthesis and biological evaluation of combretatriazoles.
    Cafici L; Pirali T; Condorelli F; Del Grosso E; Massarotti A; Sorba G; Canonico PL; Tron GC; Genazzani AA
    J Comb Chem; 2008; 10(5):732-40. PubMed ID: 18681482
    [TBL] [Abstract][Full Text] [Related]  

  • 20. In vivo and in vitro evaluation of combretastatin A-4 and its sodium phosphate prodrug.
    Grosios K; Holwell SE; McGown AT; Pettit GR; Bibby MC
    Br J Cancer; 1999 Dec; 81(8):1318-27. PubMed ID: 10604728
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.